Save
Molecular suitability of the Chacma baboon model of acquired thrombotic thrombocytopenic purpura when evaluating anti-VWF agents
ISTH Academy, Walter Janse Van Rensburg, 263784
Impact of Von Willebrand Factor deficiency on placental development and angiogenesis
ISTH Academy, Mario von Depka, 263785
Correlation of tissue factor- and phospholipid-activated thrombin generation assays with tail bleeding in hemophilia A mice treated with coagulation factor VIIa
ISTH Academy, Mikhail V. Ovanesov, 263801
Generation of Transgenic Zebrafish with RFP-Labeled Young and GFP-Labeled Mature Thrombocytes: Analysis of Their Lipids
ISTH Academy, Pudur Jagadeeswaran, 263803
The effect of Antithrombin Budapest3 mutation for the heparin binding affinity of Antithrombin
ISTH Academy, Krisztina Pénzes-Daku, 263804
Effect of Brazilian snake venoms on hemostasis evaluated by thrombin generation assay
ISTH Academy, Luci Dusse, 263818
The shortened activation peptide of Pseudonaja textilis venom FX confers zymogenicity and resistance to factor VIIIa-IXa activation
ISTH Academy, Mark Schreuder, 263819
Variability in Venom Coagulotoxins in Russell’s Vipers (genus: Daboia) Compromise Antivenom Effectiveness
ISTH Academy, Bianca op den Brouw, 263820
Plasma kallikrein contributes to coagulation by activating factor IX
ISTH Academy, Mayken Visser, 263836
Potential Contribution of Kallikrein to the Coagulation System Independent of Factor XII Activation
ISTH Academy, Juliet Butler, 263837
Misfolded proteins can differentially modulate the contact system
ISTH Academy, Lewis Hardy, 263839
Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement
ISTH Academy, Qiulan Ding, 263853
Genetic Characterization of two new Families with Congenital Factor XIII Deficiency. A new Missense Mutation of gene F13
ISTH Academy, ANGEL ZUÑIGA, 263854
Clinical and Molecular Characterization by NGS of Spanish Patients affected by Congenital Deficiency of Fibrinogen
ISTH Academy, Santiago Bonanad, 263855
Evolving Amiloride into uPA-targeting Candidates for the Treatment of Metastatic Cancer and Rheumatoid Arthritis
ISTH Academy, Benjamin Buckley, 263871
Heparanase: a potential new factor concerned to epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma
ISTH Academy, Massoud Mirshahi, 263872
Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion in carcinomatosis patients
ISTH Academy, Massoud Mirshahi, 263873
A Survey of Physicians’ Treatment Switching Practice in Long-term Prophylaxis for People with Haemophilia A in five European Countries
ISTH Academy, Sally Tawil, 263887
Long-term outcomes after switch from on-demand treatment to prophylaxis with rFIXFc: longitudinal subgroup analysis of the B-LONG and B-YOND study population
ISTH Academy, Hervé Chambost, 263888
Timing of Treated Spontaneous Bleeding in Persons with Haemophilia A (PwHA) in the HAVEN 3 Study
ISTH Academy, Johnny Mahlangu, 263889
Expert Opinion on the UK Standard of Care for Haemophilia Patients with Inhibitors: A Delphi Consensus Study
ISTH Academy, Kate Khair, 263903
Population Pharmacokinetics of rVIII-SingleChain in Obese Previously Treated Patients with Severe Hemophilia A in Study CSL627_1001
ISTH Academy, William McKeand, 263904
Emicizumab Improves Factor X Activation and Thrombin Generation Similar to Mild Hemophilia in Persons with Hemophilia A and Inhibitors
ISTH Academy, Marilyn Manco-Johnson, 263905
HOSPITALIZATION OF HEMOPHILIA A and B PATIENTS IN BRAZIL - TRENDS FROM 2004 TO 2016
ISTH Academy, ANA GUERSONI, 263920
The Impact on Australian Haemophilia Nursing Roles after the Introduction of an Interim Agreement of Extended Half Life Products for the Treatment of Haemophilia
ISTH Academy, Robyn Shoemark, 263921
ADVANCE-AF: An international, prospective, longitudinal, observational registry study of hemophilia patients with atrial fibrillation
ISTH Academy, Roger Schutgens, 263922
Effect of lower von Willebrand factor and factor XI levels on treatment success of the levonorgestrel intrauterine system or endometrial ablation in heavy menstrual bleeding - an explorative study
ISTH Academy, Karina Meijer, 263937
Educational guidance and training program for patients in the eminence of home therapy for factor XIII deficiency
ISTH Academy, Ricardo Camelo, 263938
Combined factor V and factor VIII deficiency: A Clinico-haematological Spectrum
ISTH Academy, Mostafa Paridar, 263939
Detection and Analysis of Gene Mutations in Patients with Factor VII deficiency by Next Generation Sequencing
ISTH Academy, Boyang Sun, 263953
Coexisting mild hemophilia B and von Willebrand´s disease type 1: a rare multiple congenital coagulopathy
ISTH Academy, Michael Steiner, 263954
A nightmare in congenital factor XIII deficiency:Inhibitor development with severe bleeding
ISTH Academy, Serap Karaman, 263955
Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency: A Post-marketing Observational Study
ISTH Academy, Bruce Schwartz, 263969
Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) Case report
ISTH Academy, Daniela Brito, 263970
Rare Bleeding Disorder Manifestations in Women and Girls: Experience Of One Center In Algiers
ISTH Academy, Nawel Ferroudj, 263971
Genotype-phenotype and pathophysiological mechanisms involved in patients with von Willebrand disease (VWD) type 2A and 2M according to domains affected by genetic clinical-grade variants (CGV)
ISTH Academy, Adriana Inés Woods, 263986
Gastrointestinal Angiodysplasia and Von Willebrand Disease: Our Experience of Managing Challenging Bleeding
ISTH Academy, Gary Benson, 263987
A Novel Mechanism in Severe Type 1 VWD: a Heterozygous Splicing Mutation Causes Exon 26 Skipping and Increases VWF Clearance
ISTH Academy, Mattia Ferrarese, 263988
Management of Postpartum Haemorrhage in a Woman with Type 2B Von Willebrand Disease
ISTH Academy, Samuel Ackroyd, 264002
Safety and Efficacy of pdVWF/FVIII in Patients with von Willebrand Disease Undergoing Prophylaxis: Results from a Non-interventional Multicentre Study
ISTH Academy, Joseph Lasky, 264003
Determination of Large and Ultra-large Multimers in Recombinant Human VWF (rVWF) and Pharmacokinetic Analyses in Patients with Type 3 von Willebrand Disease (VWD)
ISTH Academy, Peter. L Turecek, 264005
It takes a village… The implementation of a multidisciplinary clinic review for children and adolescents with bleeding disorders
ISTH Academy, Jaime Chase, 264021
Current Nursing Workloads and Implications for the Future within Haemophilia Treatment Centres in Australia
ISTH Academy, Susan Webzell, 264022
National benchmarking of Paediatric Haemophilia Treatment Centres
ISTH Academy, Stacey Hutchison, 264023
Therapeutic aspects, determining the outcome of deep veins thrombosis (DVT) in children with hematological diseases
ISTH Academy, Daria Fedorova, 264039
Genetic and Clinical Determinants Influencing Warfarin Dosing in Thai Children And Adolescents
ISTH Academy, Premmika Intapun, 264040
Septic Dural Sinus Thrombosis In Children
ISTH Academy, Patcharee Komvilaisak, 264041
Platelet Phenotype and Function in Paediatric Extracorporeal Membrane Oxygenation (ECMO) Circuits
ISTH Academy, Hui Ping Yaw, 264055
Endothelial and Platelet Activations in α-thalassemia Diseases
ISTH Academy, Pankamol Sirivadhanakul, 264056
Characteristics of young patients with retinal occlusion
ISTH Academy, Dorit Blickstein, 264057
THE INCIDENCEOF VENOUS THROMBOEMBOLISM IN THROMBOPHILIC CHILDREN: A PROSPECTIVE COHORT STUDY
ISTH Academy, Daniela Tormene, 264071
Multidisciplinary Approach to Pediatric Thrombosis; Istanbul Pediatric Thrombosis (I-PeT) Study Group Experience
ISTH Academy, Zeynep Karakas, 264072
Symptomatic and incidental VTE in children differs in epidemiology and outcomes
ISTH Academy, Daria Fedorova, 264073
Incidence and Risk Factors for Peripherally Inserted Central Catheter-Related Venous Thrombosis in Critically-Ill Children with Cardiac Disease: a Retrospective Single-Center Case-Control Study
ISTH Academy, Jennifer Meldau, 264089
Use of low molecular weight heparins in pediatric thromboembolism: a retrospective descriptive study
ISTH Academy, Claudia DJAMBAS KHAYAT, 264090
A 10-year case-control study on the risk factors for neonatal portal vein thrombosis
ISTH Academy, Tuan Nguyen Minh, 264091
The Interactions of Protamine and Heparin with Platelets in Rodents
ISTH Academy, Joanna Miklosz, 264105
Optimal “timing” of low-dose aspirin by aggregation and thromboelastometry tests in patients with essential thrombocythemia
ISTH Academy, Emma Cacciola, 264106
Astragalus polysaccharide promotes haematopoiesis and thrombopoiesis in irradiation mouse models
ISTH Academy, Mo Yang, 264107
The first homozygous GNE variant in the P-loop of the ManNAc kinase domain causes severe macrothrombocytopenia and bleeding
ISTH Academy, Marie-Christine Morel-Kopp, 264122
Outcome of an enhanced diagnostic pipeline for patients suspected for inherited thrombocytopenia
ISTH Academy, Eva Leinoe, 264123
Prospective comparison of Whole Mount Electron Microscopy and mepacrine based flow cytometric assay for determination of Platelet Dense Granules and Platelet Dense Granule Deficiency
ISTH Academy, Timothy Brighton, 264124
Platelet function testing: current practice among clinical centers in the Nordic countries
ISTH Academy, Riita Lassila, 264138
The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume
ISTH Academy, David Connor, 264139
Correlation between mutations and clinical features in patients with essential thrombocythemia
ISTH Academy, Mankai Ju, 264140
TLT-1 expression during megakaryocyte differentiation
ISTH Academy, Angela Doerr, 264155
The effect of a new packing container on medication adherence Department of Pharmacy
ISTH Academy, Kana Aoki, 264156
An empirical screen of the effects of polyphenolic compounds on platelet scramblase activity
ISTH Academy, Sarah Millington-Burgess, 264157
Platelet-specific factor XIII-A: A novel role in the regulation of platelet function
ISTH Academy, Joanne Mitchell, 264173
Fatal Dysfunction and Disintegration of Thrombin-Activated Platelets
ISTH Academy, John Weisel, 264175
Blood clot contraction is promoted by calpain via strengthening of the coupling of fibrin-bound αIIbβ3 to the platelet cytoskeleton
ISTH Academy, John Weisel, 264176
Effect of recombinant human lactoferrin, isolated from transgenic goats, on platelet aggregation and Ca2+-response
ISTH Academy, Ekaterina Shamova, 264190
Extracellular vesicle shedding from stimulated platelets involves phosphatidylserine exposure in addition to a functional αIIbβ3integrin
ISTH Academy, Tilman M. Hackeng, 264191
Platelet Integrin αIIbβ3-dependent Outside-in Signaling Is Regulated by Apoptosis Signal-regulating Kinase 1 Through p38 MAP Kinase Signaling
ISTH Academy, Meghna Naik, 264193
Laboratory measurement of rivaroxaban using anti-factor Xa assays in patients with cancer-associated thrombosis
ISTH Academy, Eunha Koh, 264207
Coagulation Factors and Natural Anticoagulants in Polycythemia Vera Patients, Relation with JAK2V617F Mutation Load
ISTH Academy, Natalia Silina, 264208
Improving care for patients with Cancer Associated Thrombosis in the Netherlands using patients´, caregivers´ and health care professionals´ experiences
ISTH Academy, Asiong Jie, 264209
Apixaban as treatment for Cancer Related Venous Thrombosis - A single arm interventional study
ISTH Academy, Trine-Lise Hannevik, 264224
Superficial Vein Thrombosis and Cancer
ISTH Academy, Jana Hirmerova, 264225
Coagulation profile in non Hematoloic malignancies
ISTH Academy, Sushma Belurkar, 264226
Incidence Of Venous Thromboembolism (VTE) In Childhood Cancers - Tertiary Care Centre Experience From Kingdom Of Saudi Arabia
ISTH Academy, Mahasen Saleh, 264241
Role of microRNAs in venous thromboembolic disease of patients with lung cancer
ISTH Academy, Julia Oto, 264242
DOACs and cancer-associated thrombosis: effect of online CME on knowledge and confidence of physicians
ISTH Academy, Jelena Spyropoulos, 264243
A Retrospective Analysis of the real-world use of Idarucizumab at Two Tertiary Care Centres in Toronto, Canada
ISTH Academy, Jameel Abdulrehman, 264257
Reversal of warfarin using low dose Prothromplex Total, a 4-factor prothrombin complex and its implications on fix-dosing regimens
ISTH Academy, Shu Hui Yeang, 264258
Perioperative management of anticoagulant therapies in elderly patients undergoing orthopedic surgery: preliminary results from the ORTHO-START registry
ISTH Academy, Elvira Grandone, 264259
Idarucizumab for dabigatran reversal, the first 6 months in a tertiary center
ISTH Academy, Matt Wheeler, 264260
Effect of polypharmacy on bleeding of rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism
ISTH Academy, Ingrid Bistervels, 264275
Risk factors for gastro-intestinal bleeding associated with DOACs: a case control- study
ISTH Academy, Cecilia Becattini, 264276
Factor Xa inhibitor antidote, Andexanet alfa differentially reverses the effects of Apixaban, Betrixaban, Edoxaban and Rivaroxaban
ISTH Academy, Fakiha Siddiqui, 264277
Management of oral anticoagulant reversal prior to emergency surgery: are we following guidelines in the United States?
ISTH Academy, Jerrold Levy, 264278
Effectof Anticoagulant treatment on Pain in Distal Deep Vein Thrombosis: An Ancillary Analysis from the CACTUS Trial
ISTH Academy, Marc Righini, 264293
Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequela; a retrospective cohort study performed with routine healthcare data from the Netherlands
ISTH Academy, Geert-Jan Geersing, 264294
Automated IVC filter retrieval requests and haematology liaison improves documentation and retrieval of temporary inferior vena cava filters: a quality improvement initiative
ISTH Academy, Lara N. Roberts, 264295
Outcomes in the secondary prevention of cerebral venous thrombosis in cancer only population
ISTH Academy, Cristhiam Mauricio Rojas Hernandez, 264310
Incidence and characteristics of venous thromboembolism in East Asian primary central nervous system lymphoma
ISTH Academy, Sung-Soo Yoon, 264312
Extended anticoagulation for unprovoked venous thromboembolism: a survey on physicians’ considerations and guideline adherence
ISTH Academy, Maria Adriana de Winter, 264314
Non-invasive detection of early phase of deep vein thrombus with diffusion-weighted magnetic resonance imaging
ISTH Academy, Toshihiro Gi, 264331
Incidence and characteristics of double lumen induced central venous catheter-related thromboembolism in hemodialytic patients
ISTH Academy, Andree Kurniawan, 264332
Evaluation of strategies focused on empowerment and change of behavior with a potential utility in patients with thromboembolic disorders
ISTH Academy, Luci Dusse, 264333

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings